Latest News for: cel

Edit

CIT-U, CEC complete playoffs cast in CEL Season 3 play-in tourney

The Philadelphia Inquirer 23 Mar 2025
... Eastern College (CEC) Dragons secured the last two playoff spots in the Cesafi Esports League (CEL) Season 3’s Mobile Legends.
Edit

Celsius Price Prediction 2025, 2026-2030: Will CEL Coin Hit $1?

BitRSS 21 Mar 2025
The post Celsius Price Prediction 2025, 2026-2030. Will CEL Coin Hit $1? appeared first on Coinpedia Fintech News Story Highlights The CEL price today is . The Celsius price could hit a maximum price of $ in 2025. Increased... .
Edit

Preliminary Proxy Statement (Form PRE 14A) (CEL-SCI Corporation)

Public Technologies 21 Mar 2025
CEL-SCI CORPORATION ... Notice is hereby given that the annual meeting of the shareholders of CEL-SCI Corporation ("CEL-SCI") will be held at the offices of CEL-SCI at 8229 Boone Blvd., Vienna, Virginia 22182 on May 19, 2025 at 11.00 a.m.
Edit

Abeona Therapeutics� Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory Update and Commercial Launch Plans

Nasdaq Globe Newswire 20 Mar 2025
FDA priority review of pz-cel Biologics License Application (BLA) progressing with Prescription Drug User Fee Act (PDUFA) target action date of April 29, 2025 ... .
Edit

Abeona Therapeutics® Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory

Hastings Tribune 20 Mar 2025
FDA priority review of pz-cel Biologics License Application (BLA) progressing with Prescription Drug User Fee Act (PDUFA) target action date of April 29, 2025 ... .
Edit

Abeona Therapeutics® Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory Update and Commercial Launch Plans (Form 8-K) (Abeona Therapeutics Inc)

Public Technologies 20 Mar 2025
Abeona Therapeutics® Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory Update and Commercial Launch Plans ... Food and Drug Administration (FDA) regarding prademagene zamikeracel (pz-cel) and plans for the U.S.
Edit

CEL-SCI Announces Closing of $2.5 Million Offering

Business Wire 19 Mar 2025
VIENNA, Va.--(BUSINESS WIRE)---- $CVM--CEL-SCI announces closing of $2.5 million offering ... .
Edit

Cellares and Cabaletta Bio Successfully Complete Manufacturing Technology Adoption Program for Rese-cel Using the Cell ...

The Eagle-Tribune 19 Mar 2025
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Mar 19, 2025-- ... .
Edit

Report: Canned Coyote Vs. Acme Movie Might Be Heading To Theaters After All

Kotaku 19 Mar 2025
These days I appreciate any good news we get and hold onto it for dear life. And today, the good news keeping me going is a new report that claims Warner Bros. is negotiating a deal that would finally bring the canceled Coyote Vs ... Suggested Reading ... ....
Edit

CEL-SCI ANNOUNCES PRICING OF $2.5 MILLION OFFERING (Form 8-K) (CEL-SCI Corporation)

Public Technologies 18 Mar 2025
CEL-SCI ANNOUNCES PRICING OF $2.5 MILLION OFFERING. Vienna, Virginia - March 17, 2025 - CEL-SCI Corporation ("CEL-SCI" or the "Company") (NYSE American ... About CEL-SCI Corporation ... CEL-SCI Corporation.
Edit

Care sistem ideologic este cel mai compatibil cu democrația? X Profesor Dragoș DRAGOMAN

Bitchute 18 Mar 2025
Go to the source via the article link to view the video or click the video icon ....
Edit

CEL-SCI Announces Pricing of $2.5 Million Offering

Business Wire 18 Mar 2025
VIENNA, Va.--(BUSINESS WIRE)---- $CVM--CEL-SCI announces pricing of $2.5 million offering ... .
Edit

Supplemental Prospectus (Form 424B5) (CEL-SCI Corporation)

Public Technologies 18 Mar 2025
CEL-SCI Corporation ... These publications can be accessed at http.//www.cel-sci.com ... Our telephone number is 703-506-9460 and our website is www.cel-sci.com ... CEL-SCI's current and future clinical trials may not be successful ... CEL-SCI Corporation.
Edit

CEL-SCI’s Head and Neck Cancer Registration Study Protocol Clears FDA Review—in Talks with Potential Partners ...

Business Wire 17 Mar 2025
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--Head and Neck Cancer Registration Study Protocol clears FDA review—in talks with potential partners Interested in commercialization of Multikine ... .
Edit

Journal of the American Medical Association (JAMA) Study Provides Further Evidence that CEL-SCI’s Multikine Can ...

Business Wire 14 Mar 2025
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--Journal of the American Medical Association study provides further evidence that Multikine can treat unmet need in ~70% of Head and Neck Patients ... .

Article Search

tools
×
×
×
×